BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 649009)

  • 21. Updated approach to screening for cervical cancer in older women.
    Celentano DD
    Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic accuracy of colposcopy in the detection of precancerous conditions and early forms of cervical cancer].
    Hanuszek K
    Pol Tyg Lek; 1980 Oct; 35(40):1521-4. PubMed ID: 7465446
    [No Abstract]   [Full Text] [Related]  

  • 23. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
    Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
    Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison between histologic diagnosis and cytologic finding of pre- and early stages of cervical cancer (author's transl)].
    Rohde E; Bader G; Beust M; Büttner HH; Neumann HG
    Arch Geschwulstforsch; 1977; 47(4):311-3. PubMed ID: 921485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of threatened pathology and cancer of the cervix uteri during prophylactic examinations (based on the results of a cooperative study)].
    Nikitina NI; Agamova KA; Starinskiĭ VV; Nevskaia EA; Gladunova ZD
    Vopr Onkol; 1981; 27(3):13-8. PubMed ID: 6452740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic verification of Group III and III D cytological tests with special reference to follow-up].
    Schlegel H; Kühndel K
    Zentralbl Gynakol; 1983; 105(24):1585-96. PubMed ID: 6666444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cytology: use and follow-up.
    Hurt WG
    J Fam Pract; 1978 Sep; 7(3):579-84. PubMed ID: 690590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
    Howell LP; Gurusinghe S; Tabnak F
    Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational approaches to improving cervical screening.
    Baldwin P; Laskey R; Coleman N
    Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interest of the prevention of uterine cervix cancer at prenuptial examination (author's transl)].
    Millot MJ
    Rev Epidemiol Sante Publique; 1977 Oct; 26(3):225-36. PubMed ID: 618029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
    Kasabova M
    Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
    [No Abstract]   [Full Text] [Related]  

  • 36. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
    Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
    Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pre- and early stages of cervical carcinoma. Diagnosis and treatment].
    Almendral AC; Szalmay G; Jochum L; Müller H
    Fortschr Med; 1974 Sep; 92(26):1009-14. PubMed ID: 4410465
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of cytologic examinations of the cervix in women under the age of thirty (author's transl)].
    Furch W; Cramer H
    Geburtshilfe Frauenheilkd; 1976 May; 36(5):381-7. PubMed ID: 1278659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.